Pictet Asset Management
CVAC

Pictet Asset Management’s CureVac CVAC Stock Holding History

Pictet Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-101,918
Closed -$546K – 2091
2025
Q3 		$546K Buy
101,918
+6,556
+7% +$35.5K ﹤0.01% 1345
2025
Q2 		$512K Hold
95,362
– – ﹤0.01% 1351
2025
Q1 		$265K Hold
95,362
– – ﹤0.01% 1676
2024
Q4 		$298K Hold
95,362
– – ﹤0.01% 1646
2024
Q3 		$294K Hold
95,362
– – ﹤0.01% 1622
2024
Q2 		$317K Buy
95,362
+83,289
+690% +$272K ﹤0.01% 1502
2024
Q1 		$37.2K Hold
12,073
– – ﹤0.01% 1951
2023
Q4 		$50.8K Buy
+12,073
New +$65.5K ﹤0.01% 1933

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Pictet Asset Management's CVAC Position: Q4 2025 in Review

Pictet Asset Management sold out of CureVac (CVAC) in Q4 2025, closing a stake of 101,918 shares — an estimated $546K sold.

Pictet Asset Management first reported a position in CVAC in Q4 2023 and held it in 8 quarters. The position peaked at $546K in Q3 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Pictet Asset Management reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Pictet Asset Management sold 101,918 CureVac shares in Q4 2025, an estimated $546K.
  • Pictet Asset Management first reported a position in CureVac in Q4 2023 and held it in 8 quarters.
  • Pictet Asset Management's CureVac position peaked at $546K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Pictet Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.